These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 1226254)

  • 1. [Research on some factors of hemostasis in patients with chronic uremia during conservative and dialytic therapy].
    Fiorio P; Muttini P; Lamperi S
    Minerva Nefrol; 1975; 22(2-3):83-7. PubMed ID: 1226254
    [No Abstract]   [Full Text] [Related]  

  • 2. [Research on some erythrocytic abnormalities in chronic uremic patients in conservative and dialytic therapy].
    Lamperi S; Sitia L; Bandiani G; Muttini P
    Minerva Nefrol; 1970; 17(6):175-80. PubMed ID: 5516050
    [No Abstract]   [Full Text] [Related]  

  • 3. [High levels of digoxin encountered in patients with chronic uremia undergoing a periodic hemodialytic treatment and conservative therapy].
    Filoramo F; Redaelli B; Pincella G; Sforzini S; Limido D; D'Amico P; Valagussa F
    Minerva Nefrol; 1976; 23(5):393-6. PubMed ID: 1018876
    [No Abstract]   [Full Text] [Related]  

  • 4. [Studies on the serum lipid pattern in patients with chronic uremia during conservative and hemodialytic treatment].
    Tarchini RG; Guarnieri GF; Baroni C; Campanacci L
    Minerva Nefrol; 1974; 21(6):415-21. PubMed ID: 4462026
    [No Abstract]   [Full Text] [Related]  

  • 5. [Notes on the pathogenesis and therapy of arterial hypertension in patients with chronic uremia in dialytic treatment].
    Governatori M; Romeo V; Costantini D; De Santis ML; Mendicino A; Carnabuci A; Calise R; Minisola G
    Clin Ter; 1983 Dec; 107(6):455-63. PubMed ID: 6362970
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of extracorporeal hemodialysis on some aspects of hemostatic function in chronic uremia].
    Cocconi G; Ferioli V; Franchini I
    Minerva Nefrol; 1967; 14(4):162-8. PubMed ID: 5304654
    [No Abstract]   [Full Text] [Related]  

  • 7. [Effect of hemoperfusion on various blood coagulation and fibrinolysis factors in chronic uremia].
    Lewicki R; Trznadel K; Luciak M; Kidawa Z
    Pol Tyg Lek; 1981 Aug; 36(35):1325-7. PubMed ID: 7329845
    [No Abstract]   [Full Text] [Related]  

  • 8. The current status of treatment of chronic uremia.
    Senty RF
    J Am Osteopath Assoc; 1970 Dec; 70(4):335-42. PubMed ID: 5202725
    [No Abstract]   [Full Text] [Related]  

  • 9. [The treatment of chronic uremia].
    Fritzer W; Jahn O; Pinggera W
    Wien Klin Wochenschr; 1967 Jun; 79(23):432-4. PubMed ID: 4874053
    [No Abstract]   [Full Text] [Related]  

  • 10. [Effect of chromatographic fractions of blood ultrafiltrates of patients with chronic uremia on the fibrinolytic activity]].
    Popławski A; Myśliwiec M; Soszka J
    Pol Tyg Lek; 1990 Oct 1-8; 45(40-41):810-3. PubMed ID: 2096374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of hemodialysis in chronic uremia on granulocyte adhesivity].
    Ruiz Alcantarilla P; Gómez Rodríguez F
    Med Clin (Barc); 1987 Oct; 89(14):588-91. PubMed ID: 3431184
    [No Abstract]   [Full Text] [Related]  

  • 12. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
    Attman PO; Ottosson P; Samuelsson O; Eriksson UG; Eriksson-Lepkowska M; Fager G
    Nephrol Dial Transplant; 2005 Sep; 20(9):1889-97. PubMed ID: 15928099
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevention of clot formation during haemodialysis using the direct thrombin inhibitor melagatran in patients with chronic uraemia.
    Attman PO
    Nephrol Dial Transplant; 2006 Jun; 21(6):1738. PubMed ID: 16364986
    [No Abstract]   [Full Text] [Related]  

  • 14. [Activity of various lysosomal enzymes of neutrophils in the initial period of hemodialysis in patients with chronic uremia].
    Luciak M; Trznadel K
    Pol Tyg Lek; 1983 Jul 11-18; 38(28-29):877-80. PubMed ID: 6361714
    [No Abstract]   [Full Text] [Related]  

  • 15. Fast decrease of bleeding time by tranexamic acid in uremia.
    Mezzano D; Muñoz B; Pais E; Downey P; Pereira J
    Thromb Haemost; 2000 May; 83(5):785. PubMed ID: 10823278
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of bleeding in dialysis patients.
    Galbusera M; Remuzzi G; Boccardo P
    Semin Dial; 2009; 22(3):279-86. PubMed ID: 19573008
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Study of hemostasis and coagulation in uremic patients during extra-corporeal dialysis].
    Praga C; Brancaccio D; Cortellaro M; Pisani E; Della Grazia ME
    Minerva Nefrol; 1966; 13(4):122-33. PubMed ID: 5995533
    [No Abstract]   [Full Text] [Related]  

  • 18. [Clinical selective criteria for the dialytic treatment of uremia].
    Giovannetti S
    Minerva Nefrol; 1969; 16(5):334-7. PubMed ID: 5399507
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of recombinant human erythropoietin on hemostatic status in chronic uremic patients.
    Tsao CJ; Kao RH; Cheng TY; Huang CC; Chang SL; Lee FN
    Int J Hematol; 1992 Apr; 55(2):197-203. PubMed ID: 1511168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Disorders of hemostasis and blood coagulation during uremia. 3. Role of platelet anomalies and action of hemodialysis and renal grafts].
    Moriau M
    Pathol Eur; 1966; 1(1):273-97. PubMed ID: 4865670
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.